Fig. 4

The potential lipid biomarkers responsible for anti-HLP effects of BBR. A total of 13 significantly differential lipid species were selected out by using the criteria of FC ≥ 2 or ≤ 0.5, VIP ≥ 1 and p < 0.05. CE cholesteryl esters, PE phosphatidylethanolamine, LPC lysophosphatidylcholine, HexCer Hexosylceramide. Compared with NFD group, ^*p < 0.05, ^**p < 0.01, ^***p < 0.001; Compared with HFD group, ^#p < 0.05, ^##p < 0.01). Data are presented as mean ± SD (n = 6)